These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23627241)

  • 21. ["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].
    Bücheler R; Meisner C; Kalchthaler B; Mohr H; Schröder H; Mörike K; Schwoerer P; Schwab M; Gleiter CH
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2551-7. PubMed ID: 12457324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Food and Drug Administration approval for medications used in the pediatric intensive care unit: a continuing conundrum.
    Yang CP; Veltri MA; Anton B; Yaster M; Berkowitz ID
    Pediatr Crit Care Med; 2011 Sep; 12(5):e195-9. PubMed ID: 21057369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
    Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
    Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the quality of healthcare provided to children.
    Mangione-Smith R; McGlynn EA
    Health Serv Res; 1998 Oct; 33(4 Pt 2):1059-90. PubMed ID: 9776949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Off-label use of medications: innovative prescribing or risky business?
    Martin CM
    Consult Pharm; 2010 Dec; 25(12):806-10, 813-4. PubMed ID: 21172761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discharging patients with prescriptions instead of medications: sequelae in a teaching hospital.
    Johnson KB; Butta JK; Donohue PK; Glenn DJ; Holtzman NA
    Pediatrics; 1996 Apr; 97(4):481-5. PubMed ID: 8632932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compounding slow-release capsules: a comprehensive review and an Excel spreadsheet for faster calculations of excipients.
    Zur E
    Int J Pharm Compd; 2013; 17(1):10-22. PubMed ID: 23627242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicians, pharmacists, and the importance of quality pharmacy compounding.
    Allen LV
    Int J Pharm Compd; 2013; 17(6):477-9. PubMed ID: 24579297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do Japanese children take their medicines, and what are pharmacists and paediatricians doing about it?
    Nakamura H; Ishikawa Y
    Int J Pharm; 2014 Aug; 469(2):249-50. PubMed ID: 24704105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.
    Piana C; Surh L; Furst-Recktenwald S; Iolascon A; Jacqz-Aigrain EM; Jonker I; Russo R; van Schaik RH; Wessels J; Della Pasqua OE
    J Clin Pharmacol; 2012 May; 52(5):704-16. PubMed ID: 21566202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
    Dos Santos L; Heineck I
    Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a standardized Intranet database of formulation records for nonsterile compounding, Part 2.
    Haile M; Anderson K; Evans A; Crawford A
    Int J Pharm Compd; 2012; 16(2):104-9. PubMed ID: 23050321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric drug formulations: challenges and potential solutions.
    Nahata MC
    Ann Pharmacother; 1999 Feb; 33(2):247-9. PubMed ID: 10084423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Start of reliable pediatric clinical research].
    van der Lee JH; Offringa M
    Ned Tijdschr Geneeskd; 2009; 153():A1310. PubMed ID: 19900330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing development in the pediatric office.
    Halfon N; Regalado M; Sareen H; Inkelas M; Reuland CH; Glascoe FP; Olson LM
    Pediatrics; 2004 Jun; 113(6 Suppl):1926-33. PubMed ID: 15173463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in pediatric rehabilitation.
    Burkett KW
    Nurs Clin North Am; 1989 Mar; 24(1):239-55. PubMed ID: 2522192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.